Synthesis of amino core compounds of galactosyl phytosyl ceramide analogs for developing iNKT-cell inducers

Molecules

Volumn 17, Issue 3, 2012, Pages 3058-3081

  Huang, Yin Cheng ^a   Chiang, Li Wu ^b   Chang, Kai Shiang ^b   Su, Wen Chin ^b   Lin, Yi Hsian ^b   Jeng, Kee Ching ^c   Lin, Kun I ^b,d   Liao, Kuo Yen ^b   Huang, Ho Lein ^b   Yu, Chung Shan ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHANG BING SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cancer; Glycosylation; Immune; Library; Phytosphingosine

Indexed keywords

AMINE; DRUG DERIVATIVE; GALACTOSYLCERAMIDE; SPHINGOSINE;

ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; GLYCOSYLATION; HUMAN; MOLECULAR LIBRARY; NATURAL KILLER T CELL; PHYSIOLOGY; SYNTHESIS;

AMINES; CELL SURVIVAL; CELLS, CULTURED; GALACTOSYLCERAMIDES; GLYCOSYLATION; HUMANS; NATURAL KILLER T-CELLS; SMALL MOLECULE LIBRARIES; SPHINGOSINE;

EID: 84858951825     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17033058     Document Type: Article

References (61)

1. Morita, M.; Motoki, K.; Akimoto, K.; Natori, T.; Sakai, T.; Sawa, E.; Yamaji, K.; Koezuka, Y.; Kobayashi, E.; Fukushima, H. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J. Med. Chem. 1995, 38, 2176-2187.
2. Natori, T.; Morita, M.; Akimoto, K.; Koezuka, Y. Agelasphins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas mauritianus. Tetrahedron 1994, 50, 2771-2784. (Pubitemid 24095872)
3. Singh, R.; Sharma, M.; Joshi, P.; Rawat, D. S. Clinical status of anti-cancer agents derived from marine sources. Anti-Cancer Agents Med. Chem. 2008, 8, 603-610.
4. Padron, J. M. Sphingolipids in anticancer therapy. Curr. Med. Chem. 2006, 13, 755-770.
5. Godfrey, D. I.; Kronenberg, M. Going both ways: Immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 2004, 114, 1379-1388. (Pubitemid 40385565)
6. Kawano, T.; Cui, J. Q.; Koezuka, Y.; Toura, I.; Kaneko, Y.; Motoki, K.; Ueno, H.; Nakagawa, R.; Sato, H.; Kondo, E.; et al. CD1d-restricted and TCR-mediated activation of V (alpha) 14 NKT cells by glycosylceramides. Science 1997, 278, 1626-1629. (Pubitemid 27516282)
7. Zajonc, D. M.; Cantu, C.; Mattner, J.; Zhou, D. P.; Savage, P. B.; Bendelac, A.; Wilson, I. A.; Teyton, L. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat. Immunol. 2005, 6, 810-818. (Pubitemid 43090467)
8. Kulkarni, S. S.; Gervay-Hague, J. Chemical Glycobiology I: Glycoconjugates and Carbohydrate-Protein Interactions; ACS Symposium Series 990; American Chemical Society: Washington, DC, USA, 2008; pp. 153-166.
9. Wu, D.; Fujio, M.; Wong, C.-H. Glycolipids as immunostimulating agents. Bioorg. Med. Chem. 2008, 16, 1073-1083. (Pubitemid 351191755)
10. Kinjo, Y.; Wu, D.; Kim, G. S.; Xing, G. W.; Poles, M. A.; Ho, D. D.; Tsuji, M.; Kawahara, K.; Wong, C. H.; Kronenberg, M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005, 4341, 520-525. (Pubitemid 40477061)
11. Wu, D.; Xing, G. W.; Poles, M. A.; Horowitz, A.; Kinjo, Y.; Sullivan, B.; Bodmer-Narkevitch, V.; Plettenburg, O.; Kronenberg, M.; Tsuji, M.; et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl. Acad. Sci. USA 2005, 102, 1351-1356. (Pubitemid 40209173)
12. Fujio, M.; Wu, D. G.; Garcia-Navarro, R.; Ho, D. D.; Tsuji, M.; Wong, C. H. Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: Tuning the adjuvant versus immunosuppression activity. J. Am. Chem. Soc. 2006, 128, 9022-9023. (Pubitemid 44078971)
13. Gonzalez-Aseguinolaza, G.; Van Kaer, L.; Bergmann, C. C.; Wilson, J. M.; Schmieg, J.; Kronenberg, M.; Nakayama, K.; Taniguchi, M.; Koezuka, Y.; Tsuji, M. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 2002, 195, 617-624. (Pubitemid 34461506)
14. Savage, P. B.; Teyton, L.; Bendelac, A. Glycolipids for natural killer T cells. Chem. Soc. Rev. 2006, 35, 771-779. (Pubitemid 44286272)
15. Giaccone, G.; Punt, C. J. A.; Ando, Y.; Ruijter, R.; Nishi, N.; Peters, M.; von Blomberg, B. M. E.; Scheper, R. J.; van der Vliet, H. J. J.; van den Eertwegh, A. J. M.; et al. A phase I study of the natural killer T-cell ligand alpha-Galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 2002, 8, 3702-3709. (Pubitemid 35424759)
16. Subleski, J. J.; Hall, V. L.; Wolfe, T. B.; Scarzello, A. J.; Weiss, J. M.; Chan, T.; Hodge, D. L.; Back, T. C.; Ortaldo, J. R.; Wiltrout, R. H. TCR-Dependent and -independent activation underlie liver-specific regulation of NKT cells. J. Immunol. 2011, 186, 838-847.
17. Lu, X.; Song, L.; Metelitsa, L. S.; Bittman, R. Synthesis and evaluation of an alpha-C-Galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells. ChemBioChem 2006, 7, 1750-1756. (Pubitemid 44748660)
18. Chen, W. L.; Xia, C. F.; Cai, L.; Wang, P. G. Efficient synthesis of galactosylceramide analogues for iNKT cell stimulation. Bioorg. Med. Chem. Lett. 2010, 20, 3859-3862.
19. Miyamoto, K.; Miyake, S.; Yamamura, T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing T (H) 2 bias of natural killer T cells. Nature 2001, 413, 531-534. (Pubitemid 32938752)
20. Li, Q.; Ndonye, R. M.; Illarionov, P. A.; Yu, K. O. A.; Jerud, E. S.; Diaz, K.; Bricard, G.; Porcelli, S. A.; Besra, G. S.; Chang, Y. T.; et al. Rapid identification of immunostimulatory alphagalactosylceramides using synthetic combinatorial libraries. J. Comb. Chem. 2007, 9, 1084-1093.
21. Oki, S.; Tomi, C.; Yamamura, T.; Miyake, S. Preferential T (h) 2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo. Int. Immunol. 2005, 17, 1619-1629. (Pubitemid 41754684)
22. Yu, K. O. A.; Im, J. S.; Molano, A.; Cutronc, Y.; Illarinov, P. A.; Forestier, C.; Fujiwara, N.; Arias, I.; Miyake, S.; Yamamura, T.; et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceram ides. Proc. Natl. Acad. Sci. USA 2005, 102, 3383-3388. (Pubitemid 40328054)
23. Im, J. S.; Arora, P.; Bricard, G.; Molano, A.; Venkataswamy, M. M.; Baine, I.; Jerud, E. S.; Goldberg, M. F.; Baena, A.; Yu, K. O. A.; et al. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity 2009, 30, 888-898.
24. Yang, G. L.; Schmieg, J.; Tsuji, M.; Franck, R. W. The C-glycoside analogue of the immunostimulant alpha-galactosylceramide (KRN7000): Synthesis and striking enhancement of activity. Angew. Chem. Int. Ed. 2004, 43, 3818-3822. (Pubitemid 39257501)
25. Goff, R. D.; Gao, Y.; Mattner, J.; Zhou, D. P.; Yin, N.; Cantu, C.; Teyton, L.; Bendelac, A.; Savage, P. B. Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells. J. Am. Chem. Soc. 2004, 126, 13602-13603. (Pubitemid 39407224)
26. Trappeniers, M.; Van Beneden, K.; Decruy, T.; Hillaert, U.; Linclau, B.; Elewaut, D.; Van Calenbergh, S. 6'-Derivatised alpha-GalCer analogues capable of inducing strong CD1dmediated Th1-biased NKT cell responses in mice. J. Am. Chem. Soc. 2008, 130, 16468-16469.
27. Koch, M.; Stronge, V. S.; Shepherd, D.; Gadola, S. D.; Mathew, B.; Ritter, G.; Fersht, A. R.; Besra, G. S.; Schmidt, R. R.; Jones, E. Y.; et al. The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat. Immunol. 2005, 6, 819-826. (Pubitemid 43090468)
28. Borg, N. A.; Wun, K. S.; Kjer-Nielsen, L.; Wilce, M. C. J.; Pellicci, D. G.; Koh, R.; Besra, G. S.; Bharadwaj, M.; Godfrey, D. I.; McCluskey, J.; et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 2007, 448, 44-49. (Pubitemid 47037002)
29. Liu, Y.; Goff, R. D.; Zhou, D. P.; Mattner, J.; Sullivan, B. A.; Khurana, A.; Cantu, C.; Ravkov, E. V.; Lbegbu, C. C.; Altman, J. D.; et al. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods 2006, 312, 34-39. (Pubitemid 43795980)
30. Xia, C. F.; Zhang, W. P.; Zhang, Y. L.; Woodward, R. L.; Wang, J. H.; Wang, P. G. Facile synthesis of biotin-labelled alpha-galactosylceramide as antigen for invariant natural killer T cells. Tetrahedron 2009, 65, 6390-6395.
31. Liu, Y.; Goff, R. D.; Zhou, D. P.; Mattner, J.; Sullivan, B. A.; Khurana, A.; Cantu, C.; Ravkov, E. V.; Lbegbu, C. C.; Altman, J. D.; et al. Synthesis and NKT cell stimulating properties of fluorophore-and biotin-appended 6"-amino-6"-deoxy-galactosylceramides. Org. Lett. 2002, 4, 1267-1270.
32. Prigozy, T. I.; Naidenko, O.; Qasba, P.; Elewaut, D.; Brossay, L.; Khurana, A.; Natori, T.; Koezuka, Y.; Kulkarni, A.; Kronenberg, M. Glycolipid antigen processing for presentation by CD1d molecules. Science 2001, 291, 664-667. (Pubitemid 32150427)
33. Jervis, P. J.; Cox, L. R.; Besra, G. S. Synthesis of a versatile building block for the preparation of 6-N-derivatized alpha-galactosyl ceramides: Rapid access to biologically active glycolipids. J. Org. Chem. 2011, 76, 320-323.
34. Schombs, M.; Park, F. E.; Du, W. J.; Kulkarni, S. S.; Gervay-Hague, J. One-pot syntheses of immunostimulatory glyeolipids. J. Org. Chem. 2010, 75, 4891-4898.
35. Du, W. J.; Gervay-Hague, J. Efficient synthesis of alpha-galactosyl ceramide analogues using glycosyl iodide donors. Org. Lett. 2005, 7, 2063-2065. (Pubitemid 40732049)
36. Du, W.; Kulkarni, S. S.; Gervay-Hague, J. Efficient, one-pot syntheses of biologically active alpha-linked glycolipids. Chem. Commun. 2007, 23, 2336-2338. (Pubitemid 46889434)
37. Xing, G. W.; Wu, D.; Poles, M. A.; Horowitz, A.; Tsuji, M.; Ho, D. D.; Wong, C. H. Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramides. Bioorg. Med. Chem. 2005, 13, 2907-2916. (Pubitemid 40387499)
38. Schmidt, R. R.; Zimmermann, P. Glycosylimidates. 23. synthesis of glycosphingolipids and psychosines. Angew. Chem. Int. Ed. Engl. 1986, 25, 725-726.
39. Chiang, L. W.; Pei, K.; Chen, S. W.; Huang, H. L.; Lin, K. J.; Yen, T. C.; Yu, C. S. Combining a solution-phase derived library with in-situ cellular bioassay: Prompt screening of amide-forming minilibraries using mtt assay. Chem. Pharm. Bull. 2009, 57, 714-718.
40. Su, Y. H.; Chiang, L. W.; Jeng, K. C.; Huang, H. L.; Chen, J. T.; Lin, W. J.; Huang, C. W.; Yu, C. S. Solution-phase parallel synthesis and screening of anti-tumor activities from fenbufen and ethacrynic acid libraries. Bioorg. Med. Chem. Lett. 2011, 21, 1320-1324.
41. Zhang, L.; Sun, F.; Li, Y. X.; Sun, X.; Liu, X. M.; Huang, Y. S.; Zhang, L. H.; Ye, X. S.; Xiao, J. Rapid synthesis of iminosugar derivatives for cell-based in situ screening: Discovery of "Hit" compounds with anticancer activity. ChemMedChem 2007, 2, 1594-1597.
42. Lin, K.-I.; Yang, C.-H.; Huang, C.-W.; Jian, J.-Y.; Huang, Y.-C.; Yu, C.-S. Synthesis and structure-activity relationships of fenbufen amide analogs. Molecules 2010, 15, 8796-8803.
43. Su, W.-C. Preparation of 6-amino galactosyl sphingosine analogs and its elaboration to amide libraries. Master thesis, National Tsing-Hua University, Hsinchu, Taiwan, 2010.
44. Chiang, L.-W.; Pan, S.-D.; Lo, J.-M.; Yu, C.-S. Triflic acid-promoted formylation of ceramide in dimethylformamide. Chin. J. Chem. 2009, 27, 2296-2299.
45. Garner, P.; Park, J. M. The synthesis and configurational stability of differentially protected betahydroxy-alpha-amino aldehydes. J. Org. Chem. 1987, 52, 2361-2364.
46. Alper, P.-B.; Hung, S.-C.; Wong, C.-H. Metal catalyzed diazo transfer for the synthesis of azides from amines. Tetrahedron Lett. 1996, 37, 6029-6032. (Pubitemid 26259506)
47. Kuroda, I.; Musman, M.; Ohtani, I.; Ichiba, T.; Tanaka, J.; Gravalos, D. G.; Higa, T. Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, Pachastrissa sp. J. Nat. Prod. 2002, 65, 1505-1506. (Pubitemid 35239644)
48. Noyce, D. S.; Virglio, J. A. Synthesis and solvolysis of 1-phenylethyl disubstituted phosphinates. J. Org. Chem. 1972, 37, 2643-2647.
49. Yu, C.-S.; Wang, R.-T.; Chiang, L.-W.; Lee, M.-H. Synthesis of 4', 4'-C-diaminomethyl nucleoside derivative as a building block for constructing libraries via amide bond formation. Tetrahedron Lett. 2007, 48, 2979-2982. (Pubitemid 46483602)
50. Jagdhane, R. C.; Shashidhar, M. S. Orthogonally protected cyclohexanehexols by a "One Reaction-One Product" approach: Efficient access to cyclitols and their analogs. Eur. J. Org. Chem. 2010, 2945-2953.
51. Mitra, A.; DePue, L. J.; Struss, J. E.; Patel, B. P.; Parkin, S.; Atwood, D. A. Mononuclear Schiff base boron halides: Synthesis, characterization, and dealkylation of trimethyl phosphate. Inorg. Chem. 2006, 45, 9213-9224.
52. Keizer, T. S.; DePue, L. J.; Parkin, S.; Atwood, D. A. Boron halide chelate compounds and their activity towards the demethylation of trimethylphosphate. Can. J. Chem. 2002, 80, 1463-1468. (Pubitemid 36002643)
53. Patel, A.; Lindhorst, T. K. Synthesis of "mixed type" oligosaccharide mimetics based on a carbohydrate scaffold. Eur. J. Org. Chem. 2002, 1, 79-86.
54. Plettenburg, O.; Bodmer-Narkevitch, V.; Wong, C.-H. Synthesis of alpha-galactosyl ceramide, a potent immunostimulatory agent. J. Org. Chem. 2002, 67, 4559-4564. (Pubitemid 34700817)
55. Hansen, H. C.; Magnusson, G. Synthesis of selected aminodeoxy analogues of galabiose and globotriose. Carbohydr. Res. 1999, 322, 166-180. (Pubitemid 30035446)
56. Greenberg, W. A.; Priestley, E. S.; Sears, P. S.; Alper, P. B.; Rosenbohm, C.; Hendrix, M.; Hung, S. C.; Wong, C. H. Design and synthesis of new aminoglycoside antibiotics containing neamine as an optimal core structure: Correlation of antibiotic activity with in vitro inhibition of translation. J. Am. Chem. Soc. 1999, 121, 6527-6541.
57. Mydock, L. K.; Demchenko, A. V. Superarming the S-benzoxazolyl glycosyl donors by simple 2-O-benzoyl-3, 4, 6-tri-O-benzyl protection. Org. Lett. 2008, 10, 2103-2106.
58. Morales-Serna, J. A.; Boutureira, O.; Diaz, Y.; Matheu, M. I.; Castillon, S. Recent advances in the glycosylation of sphingosines and ceramides. Carbohydr. Res. 2007, 342, 1595-1612. (Pubitemid 47058053)
59. Xia, C. F.; Yao, Q. J.; Schumann, J.; Rossy, E.; Chen, W. L.; Zhu, L. Z.; Zhang, W. P.; De Libero, G.; Wang, P. G. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3). Bioorg. Med. Chem. Lett. 2006, 16, 2195-2199. (Pubitemid 43351077)
60. Polt, R.; Szabo, L.; Treiberg, J.; Li, Y.; Hruby, V. J. General methods for alpha-o-ser/thr or beta-oser/thr glycosides and glycopeptides solid phase synthesis of o-glycosyl cyclic enkephalin analogs. J. Am. Chem. Soc. 1992, 114, 10249-10258. (Pubitemid 23032646)
61. Fan, G. T.; Pan, Y. S.; Lu, K. C.; Cheng, Y. P.; Lin, W. C.; Lin, S.; Lin, C. H.; Wong, C. H.; Fang, J. M.; Lin, C. C. Synthesis of alpha-galactosyl ceramide and the related glycolipids for evaluation of their activities on mouse splenocytes. Tetrahedron 2005, 61, 1855-1862. (Pubitemid 40178760)